Nova Mentis Life Stock Today
| NMLSF Stock | USD 0.03 0 6.14% |
Performance9 of 100
| Odds Of DistressOver 77
|
Nova Mentis is trading at 0.026 as of the 2nd of December 2024. This is a 6.14% down since the beginning of the trading day. The stock's lowest day price was 0.026. Nova Mentis has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Nova Mentis Life are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 13th of December 2022 and ending today, the 2nd of December 2024. Click here to learn more.
Nova Mentis Life Science Corp., through its subsidiaries, engages in developing diagnostics and psilocybin based therapeutics for neuroinflammatory conditions with a focus on autism spectrum disorder and fragile X syndrome in Canada. Nova Mentis Life Science Corp. The company has 143.47 M outstanding shares. More on Nova Mentis Life
Moving against Nova Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Nova Pink Sheet Highlights
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Nova Mentis Life [NMLSF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.7 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nova Mentis's market, we take the total number of its shares issued and multiply it by Nova Mentis's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Nova Mentis Life classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 143.47 M outstanding shares.
Nova Mentis Life has accumulated about 634.36 K in cash with (1.95 M) of positive cash flow from operations.
Check Nova Mentis Probability Of Bankruptcy
Ownership AllocationNova Mentis Life maintains a total of 143.47 Million outstanding shares. Nova Mentis Life secures 11.73 % of its outstanding shares held by insiders and 0.007 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Nova Ownership Details
Nova Mentis Life Risk Profiles
| Mean Deviation | 14.49 | |||
| Semi Deviation | 16.57 | |||
| Standard Deviation | 26.54 | |||
| Variance | 704.13 |
Nova Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Nova Mentis without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
Nova Mentis Corporate Management
| William Rascan | CEO Pres | Profile | |
| Kelly Pladson | Co Sec | Profile | |
| Stephen Glazer | Chief Director | Profile | |
| Jacqueline McConnell | COO Director | Profile |
Other Information on Investing in Nova Pink Sheet
Nova Mentis financial ratios help investors to determine whether Nova Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nova with respect to the benefits of owning Nova Mentis security.